CN Patent

CN117357485B — 一种改良的可吸入的载体颗粒及应用

Assigned to Jewim Pharmaceutical Shandong Co ltd · Expires 2024-09-24 · 2y expired

What this patent protects

本发明涉及一种可吸入的载体颗粒，所述载体颗粒为包括表面活性剂、玻璃态稳定剂、悬浮性能调节剂形成的乳液经喷雾干燥形成的多孔颗粒。本发明的载体颗粒具有更好的悬浮性能，可明显提高药物颗粒的混悬性能、体外微细粒子剂量和体内生物利用度。

USPTO Abstract

本发明涉及一种可吸入的载体颗粒，所述载体颗粒为包括表面活性剂、玻璃态稳定剂、悬浮性能调节剂形成的乳液经喷雾干燥形成的多孔颗粒。本发明的载体颗粒具有更好的悬浮性能，可明显提高药物颗粒的混悬性能、体外微细粒子剂量和体内生物利用度。

Drugs covered by this patent

Patent Metadata

Patent number: CN117357485B
Jurisdiction: CN
Classification: —
Expires: 2024-09-24
Drug substance claim: No
Drug product claim: No
Assignee: Jewim Pharmaceutical Shandong Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.